{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T19:01:19Z","timestamp":1788289279081,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.humpath.2025.105771","type":"journal-article","created":{"date-parts":[[2025,4,7]],"date-time":"2025-04-07T01:44:35Z","timestamp":1743990275000},"page":"105771","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Primary urethral adenocarcinoma harbors recurrent KRAS and EGFR alterations"],"prefix":"10.1016","volume":"157","author":[{"given":"Ting","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. John","family":"Iafrate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0444-0068","authenticated-orcid":false,"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2025.105771_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2017.10.013","article-title":"Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: results from the National Cancer Data Base","volume":"36","author":"Royce","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.humpath.2025.105771_bib2","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.3800317","article-title":"Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity","volume":"18","author":"Curtis","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib3","series-title":"Urinary and male genital tumours","year":"2022"},{"key":"10.1016\/j.humpath.2025.105771_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1056\/NEJMcpc1005310","article-title":"Case records of the Massachusetts General Hospital. Case 5-2011. A 65-year-old man with hematuria after treatment for prostate cancer","volume":"364","author":"Kaufman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105771_bib5","first-page":"9284","article-title":"Secondary mucinous carcinoma of the prostate after low dose rate brachytherapy","volume":"25","author":"Murchison","year":"2018","journal-title":"Can J Urol"},{"key":"10.1016\/j.humpath.2025.105771_bib6","article-title":"Mucinous adenocarcinoma of the prostatic urethra following a remote history of primary brachytherapy for prostate cancer","volume":"8","author":"Peak","year":"2020","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib7","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.humpath.2022.07.018","article-title":"Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series","volume":"128","author":"Zhao","year":"2022","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/his.15118","article-title":"Primary mucinous adenocarcinoma of the urethra: a clinicopathological analysis of 35 cases","volume":"84","author":"Ge","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105771_bib9","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1007\/s11255-023-03518-z","article-title":"Mucinous adenocarcinoma of the prostatic urethra after brachytherapy","volume":"55","author":"Isharwal","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.humpath.2025.105771_bib10","doi-asserted-by":"crossref","first-page":"e727","DOI":"10.1016\/j.clgc.2016.11.001","article-title":"Comprehensive genomic analysis of metastatic mucinous urethral adenocarcinoma guides precision oncology treatment: targetable EGFR amplification leading to successful treatment with erlotinib","volume":"15","author":"Bryce","year":"2017","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.humpath.2025.105771_bib11","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41379-020-00655-z","article-title":"Intestinal metaplasia of the urinary tract harbors potentially oncogenic genetic variants","volume":"34","author":"Acosta","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib12","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1016\/j.juro.2008.08.040","article-title":"Urethral diverticula in 90 female patients: a study with emphasis on neoplastic alterations","volume":"180","author":"Thomas","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.humpath.2025.105771_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1067\/mob.2003.246","article-title":"Urethral adenocarcinoma associated with urethral diverticulum in a patient with progressive voiding dysfunction","volume":"188","author":"von Pechmann","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.humpath.2025.105771_bib14","article-title":"Adenocarcinoma of the urethra: a rare subtype of urethral cancer","volume":"37","author":"Viswambaram","year":"2021","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib15","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000083554","article-title":"Experience with primary urethral carcinoma from the Blackfoot disease-endemic area of South Taiwan: increased frequency of bulbomembranous adenocarcinoma?","volume":"74","author":"Tsai","year":"2005","journal-title":"Urol Int"},{"key":"10.1016\/j.humpath.2025.105771_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/emmm.201000070","article-title":"Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine","volume":"2","author":"Dias-Santagata","year":"2010","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.humpath.2025.105771_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00428-023-03565-y","article-title":"Morphologic spectrum of the epithelial tumors of the male and female urethra","volume":"483","author":"Cimadamore","year":"2023","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.105771_bib18","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1006\/gyno.2000.5968","article-title":"Female urethral adenocarcinoma arising from urethritis glandularis","volume":"79","author":"Chan","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.humpath.2025.105771_bib19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/his.12661","article-title":"Intestinal metaplasia of the bladder with dysplasia: a risk factor for carcinoma?","volume":"67","author":"Gordetsky","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105771_bib20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1097\/PAS.0b013e31802ff7c4","article-title":"Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases","volume":"31","author":"Osunkoya","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib21","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.3748\/wjg.14.3866","article-title":"Nuclear beta-catenin expression as a prognostic factor in advanced colorectal carcinoma","volume":"14","author":"Elzagheid","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.humpath.2025.105771_bib22","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/(SICI)1097-0215(19990812)82:4<504::AID-IJC6>3.0.CO;2-6","article-title":"beta-catenin expression in primary and metastatic colorectal carcinoma","volume":"82","author":"Hugh","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2025.105771_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155273","article-title":"Primary mucinous adenocarcinoma of the urethra: a contemporary clinicopathologic analysis of 17 patients","volume":"256","author":"Alrohaibani","year":"2024","journal-title":"Pathol Res Pract"},{"key":"10.1016\/j.humpath.2025.105771_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/modpathol.2012.229","article-title":"Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers","volume":"26","author":"Rao","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib25","article-title":"Treatment of villous adenoma with underlying adenocarcinoma of the prostatic urethra using combined chemoradiation: a case report","volume":"16","author":"Corsi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.humpath.2025.105771_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/medicina59010109","article-title":"Management of primary female urethral adenocarcinoma: two rare case reports and literature review","volume":"59","author":"Tian","year":"2023","journal-title":"Medicina"},{"key":"10.1016\/j.humpath.2025.105771_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2021-248507","article-title":"Primary mucinous cell adenocarcinoma of female urethra","volume":"15","author":"Banthia","year":"2022","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib28","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.21037\/tcr-22-1547","article-title":"Imaging features of primary mucinous adenocarcinoma of bladder outlet and urethra: a case report and literature review","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Cancer Res"},{"key":"10.1016\/j.humpath.2025.105771_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.urology.2020.09.039","article-title":"Urethral mucinous adenocarcinoma of the prostate: an uncommon and diagnostically complex disease","volume":"146","author":"Wang","year":"2020","journal-title":"Urology"},{"key":"10.1016\/j.humpath.2025.105771_bib30","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.clinimag.2020.06.012","article-title":"MRI of prostatic urethral mucinous urothelial carcinoma: expanding the differential diagnosis for T2 hyperintense prostatic masses","volume":"68","author":"Patel","year":"2020","journal-title":"Clin Imag"},{"key":"10.1016\/j.humpath.2025.105771_bib31","doi-asserted-by":"crossref","first-page":"891","DOI":"10.12998\/wjcc.v7.i7.891","article-title":"Villous adenoma coexistent with focal well-differentiated adenocarcinoma of female urethral orifice: a case report and review of literature","volume":"7","author":"Qin","year":"2019","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.humpath.2025.105771_bib32","first-page":"267","article-title":"Mucinous adenocarcinoma of the male urethra: a report of two cases","volume":"37","author":"Raspollini","year":"2015","journal-title":"Anal Quant Cytopathol Histpathol"},{"key":"10.1016\/j.humpath.2025.105771_bib33","first-page":"38","article-title":"Adenocarcinoma of the urethra with mucinous features","volume":"17","author":"Satyanarayan","year":"2015","journal-title":"Rev Urol"},{"key":"10.1016\/j.humpath.2025.105771_bib34","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2490-14-39","article-title":"Primary mucin-producing urothelial-type adenocarcinoma of the prostatic urethra diagnosed on TURP: a case report and review of literature","volume":"14","author":"Sebesta","year":"2014","journal-title":"BMC Urol"},{"key":"10.1016\/j.humpath.2025.105771_bib35","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.humpath.2015.09.014","article-title":"Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis","volume":"47","author":"Harari","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib36","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/1097-0142(19870901)60:5<1038::AID-CNCR2820600519>3.0.CO;2-#","article-title":"Adenocarcinoma of the urethra in women. A clinicopathologic study","volume":"60","author":"Meis","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2025.105771_bib37","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.1016\/j.asjsur.2023.07.143","article-title":"Primary enteric adenocarcinoma of the female urethra: a case report","volume":"46","author":"Li","year":"2023","journal-title":"Asian J Surg"},{"key":"10.1016\/j.humpath.2025.105771_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.4103\/IJPM.IJPM_745_16","article-title":"A rare case of primary female urethral adenocarcinoma: columnar type with colonic adenocarcinoma features","volume":"61","author":"Gangadhar","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"key":"10.1016\/j.humpath.2025.105771_bib39","doi-asserted-by":"crossref","first-page":"E499","DOI":"10.5489\/cuaj.399","article-title":"Primary proximal urethral adenocarcinoma: case report and brief review","volume":"7","author":"Siosaki","year":"2013","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.humpath.2025.105771_bib40","first-page":"1426","article-title":"Primary signet ring cell carcinoma of the male urethra","volume":"16","author":"Joseph","year":"2022","journal-title":"ecancermedicalscience"},{"key":"10.1016\/j.humpath.2025.105771_bib41","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jscr\/2011.4.2","article-title":"Signet ring adenocarcinoma of a urethral diverticulum","volume":"2011","author":"Grimsby","year":"2011","journal-title":"J Surg Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib42","article-title":"Primary adenocarcinoma of bulbomembranous urethra: an exceedingly rare carcinoma in a male patient","volume":"26","author":"Stukalin","year":"2019","journal-title":"Urol Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib43","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/iju5.12672","article-title":"Mucin-producing urothelial-type adenocarcinoma of the prostate with sarcomatoid features and novel molecular phenotype","volume":"7","author":"Renavikar","year":"2023","journal-title":"IJU Case Rep"},{"key":"10.1016\/j.humpath.2025.105771_bib44","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/modpathol.2017.33","article-title":"Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma","volume":"30","author":"Roy","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/PAP.0000000000000268","article-title":"Molecular genetic features of primary nonurachal enteric-type adenocarcinoma, urachal adenocarcinoma, mucinous adenocarcinoma, and intestinal metaplasia\/adenoma: review of the literature and next-generation sequencing study","volume":"27","author":"Pires-Luis","year":"2020","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib46","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/j.1365-2559.2012.04309.x","article-title":"KRAS mutation is present in a small subset of primary urinary bladder adenocarcinomas","volume":"61","author":"Alexander","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.humpath.2025.105771_bib47","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s00428-020-02787-8","article-title":"Comparative genomic profiling of glandular bladder tumours","volume":"477","author":"Maurer","year":"2020","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2025.105771_bib48","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/JTO.0b013e318227e8c6","article-title":"Activity of epidermal growth factor receptor-tyrosine kinase inhibitors in patients with non-small cell lung cancer harboring rare epidermal growth factor receptor mutations","volume":"6","author":"De Pas","year":"2011","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.humpath.2025.105771_bib49","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1158\/1078-0432.CCR-10-3408","article-title":"Effectiveness of tyrosine kinase inhibitors on \"uncommon\" epidermal growth factor receptor mutations of unknown clinical significance in non-small cell lung cancer","volume":"17","author":"Wu","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105771_bib50","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1158\/1078-0432.CCR-08-1757","article-title":"Functional analysis of epidermal growth factor receptor (EGFR) mutations and potential implications for EGFR targeted therapy","volume":"15","author":"Kancha","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.humpath.2025.105771_bib51","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2025.105771_bib52","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/modpathol.2013.132","article-title":"EGFR alterations and EML4-ALK rearrangement in primary adenocarcinoma of the urinary bladder","volume":"27","author":"Alexander","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib53","first-page":"749","article-title":"Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma","volume":"19","author":"Lianidou","year":"1999","journal-title":"Anticancer Res"},{"key":"10.1016\/j.humpath.2025.105771_bib54","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1073\/pnas.1431692100","article-title":"Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis","volume":"100","author":"Kato","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.humpath.2025.105771_bib55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/PAS.0b013e318030718d","article-title":"CDKN2A (INK4A-ARF) mutation analysis to distinguish cutaneous melanoma metastasis from a second primary melanoma","volume":"31","author":"Blokx","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2025.105771_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines8100404","article-title":"Identification of germline mutations in melanoma patients with early onset, double primary tumors, or family cancer history by NGS analysis of 217 genes","volume":"8","author":"Stolarova","year":"2020","journal-title":"Biomedicines"},{"key":"10.1016\/j.humpath.2025.105771_bib57","article-title":"Analysis of MDM2 amplification: next-generation sequencing of patients with diverse malignancies","volume":"2018","author":"Kato","year":"2018","journal-title":"JCO Precis Oncol"},{"key":"10.1016\/j.humpath.2025.105771_bib58","doi-asserted-by":"crossref","first-page":"5835","DOI":"10.1128\/MCB.24.13.5835-5843.2004","article-title":"Amplification of Mdmx (or Mdm4) directly contributes to tumor formation by inhibiting p53 tumor suppressor activity","volume":"24","author":"Danovi","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.humpath.2025.105771_bib59","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/387299a0","article-title":"Regulation of p53 stability by Mdm2","volume":"387","author":"Kubbutat","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2025.105771_bib60","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1158\/2159-8290.CD-24-0217","article-title":"Efficacy and safety of adagrasib plus cetuximab in patients with KRASG12C-mutated metastatic colorectal cancer","volume":"14","author":"Yaeger","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.humpath.2025.105771_bib61","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2204619","article-title":"Adagrasib in non-small-cell lung cancer harboring a KRAS(G12C) mutation","volume":"387","author":"Janne","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.humpath.2025.105771_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41586-023-06123-3","article-title":"Pan-KRAS inhibitor disables oncogenic signalling and tumour growth","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2025.105771_bib63","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1200\/JCO.21.02453","article-title":"Epidermal growth factor receptor inhibition in epidermal growth factor receptor-amplified gastroesophageal cancer: retrospective global experience","volume":"40","author":"Maron","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2025.105771_bib64","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S1470-2045(12)70086-4","article-title":"Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial","volume":"13","author":"Yang","year":"2012","journal-title":"Lancet Oncol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817725000589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T07:58:24Z","timestamp":1745222304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817725000589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":64,"alternative-id":["S0046817725000589"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105771","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary urethral adenocarcinoma harbors recurrent KRAS and EGFR alterations","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2025.105771","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105771"}}